screener
PDG Realty -9.5%: sell signal in week 11, with the short up 83.76%
Trading latinoamerica: PDG Realty stock falls 9.5% and the sell signal, now in week 11, stays in management with the short up 83.76%. With quarterly results out on November 13, our model suggests managing the trade with discipline.
PG&E +2.2%: the short stays 7.34% in profit in week 11 of the sell signal
PG&E stock rises 2.2%, while the sell signal, now in week 11, stays in its management phase with the short 7.34% in profit. Our model suggests following the trade with discipline, without getting distracted by the bounce.
Petroleo Brasileiro -1.0%: the short has already cleared both model targets
Petroleo Brasileiro stock slips 1.0% while the sell signal sits in week 3, with the short up 16.83%. Price has already moved past both targets, and our model advises against opening a new short at this stage.
Palo Alto Networks +2.7%: short 15.32% in profit with November 18 earnings ahead
Palo Alto Networks stock rises 2.7% as the sell signal, in week 4, keeps the short 15.32% in profit. Our model advises against opening a fresh short and flags November 18 earnings, which could bring wide swings.
Occidental Petroleum +4.2%: the sell signal comes under pressure in week 2
Occidental Petroleum stock rises 4.2%, putting pressure on the sell signal, now in week 2. Our model advises against opening a fresh short: historically, short selling on the signal has lost money on average, because shares tend to rise over time.
Oscar Health +1.3%: buy signal up 114.88% in week 31, model coverage complete
Oscar Health stock gains 1.3%, with the buy signal in week 31 and in its management phase. Our model's coverage is complete, and only the residual capital carries on, now sitting on a 114.88% gain since the trade was opened.
Oracle +8.0%: the short stays in profit as the trade enters its management phase
Oracle stock jumps 8.0%, yet the sell signal in week 5 holds and the short is still 2.25% in profit. This week the trade moves into its management phase, which our model suggests following with discipline.
Orange +3.4%: buy signal in its confirmation week, with a standard size
Orange stock gains 3.4% and the buy signal is in its confirmation week, 3.41% up since entry. Our model indicates a standard position size, with the next scaling-out window, for 10% of the position, due in week 6.
L'Oreal +0.3%: buy signal in week 24 sits 17.95% up, model coverage complete
L'Oreal stock edges up 0.3%, and the buy signal, now in week 24, stays in its management phase, 17.95% up since entry. The model's coverage is complete, with every reference level already reached and the residual capital still running.
Opendoor Technologies -15%: the short, in its management phase, is up 73.73%
Opendoor Technologies stock falls 15% while the sell signal, now in week 26, stays in its management phase. The short is 73.73% in profit since entry, and our model suggests carrying on with the trade and managing it with discipline.
Ondas -3.3%: sell signal in its management phase, short up 32.28%
Ondas stock slips 3.3% as the sell signal, now in week 11, stays in its management phase. The short is 32.28% in profit since entry, and our model suggests running this US tech stock trade with discipline.
OEF +2.3%: sell signal in week 3, opening a short now carries high risk
OEF, the S&P 100 ETF, gains 2.3% while its sell signal moves into week 3. Our technical analysis flags a short opened now as high risk, so the model keeps tracking the ETF on a weekly basis until the picture becomes clearer.
Novo Nordisk +3.3%: buy signal in its confirmation week, standard size advised
Novo Nordisk stock gains 3.3% and the buy signal sits in its confirmation week, 3.27% up since entry. Our model indicates a standard position size and places the next scaling-out window in week 6, for 10% of the position.
NVIDIA -12.7%: short up 22.81% with both targets passed, earnings Nov 17
NVIDIA stock falls 12.7% and the sell signal, now in week 4, has the short 22.81% in profit. Our model advises against opening a fresh short and flags the November 17 earnings report, which could move the price sharply.